Smartlab Europe

IT & Data Management

Regulators Agree To Work Together On The Unification of RWE

Real-world evidence (RWE) should be included in regulatory decision-making, according to a declaration backed by both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The International Coalition of Medicines Regulatory Authorities (ICMRA) released a...

Shimadzu’s Nexera XS Inert Chromatography System Enhances Biopharma Analysis

Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in biopharma analysis. Shimadzu launched its new Nexera XS inert, a bioinert and biocompatible ultra-high performance liquid chromatograph (UHPLC), in July 2022. The system is designed to...

MaineHealth Turned COVID-19 Award Into Telehealth Scheme

Similar to several other health systems around the nation, COVID-19 forced MaineHealth to act quickly to care for patients remotely in order to protect both individuals and care teams. The Issue According to Lizzy Mulcahy, director of telehealth at the Portland,...

Novartis Victim of Cyberattack But No Sensitive Data Leaked

Cyberattacks affect everyone, including pharmaceutical behemoths like Novartis. The week ending June 4th, specialised IT website Bleeping Computer revealed that Industrial Spy, a hacker gang that operates an extortion marketplace trading stolen information, posted data supposedly taken from Novartis. Fortunately...

RCPE and InSilicoTrials to Digitalize and Accelerate the Development of Pharmaceutical Manufacturing Processes

RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialize the XPS simulation software. Specifically developed for pharmaceutical applications, XPS allows companies to assess their process configurations in unprecedented detail and explore the decision space without time- and...

Ashfield Engage acquires smart data organization PROPENSITY4

Ashfield Engage, part of UDG Healthcare has acquired PROPENSITY4 - a ‘smart data’ organization and leader in the healthcare insights and analytics arena. PROPENSITY4 integrates internal and external data assets and applies the right methodologies to derive detailed insight using...

Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform

Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and biotech industry – announces that it has integrated drug substance into its flagship Translational Pharmaceutics® platform. The newly...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »